enow.com Web Search

  1. Ads

    related to: medication list for pulmonary hypertension patients treatment guidelines

Search results

  1. Results from the WOW.Com Content Network
  2. Selexipag - Wikipedia

    en.wikipedia.org/wiki/Selexipag

    Selexipag, sold under the brand name Uptravi, is a medication developed by Actelion for the treatment of pulmonary arterial hypertension (PAH). [3] [4] Selexipag and its active metabolite, ACT-333679 (or MRE-269, the free carboxylic acid), are agonists of the prostacyclin receptor, which leads to vasodilation in the pulmonary circulation. [5]

  3. Pulmonary hypertension - Wikipedia

    en.wikipedia.org/wiki/Pulmonary_hypertension

    Treatment of pulmonary hypertension is determined by whether the PH is arterial, venous, hypoxic, thromboembolic, or miscellaneous. If it is caused by left heart disease, the treatment is to optimize left ventricular function by the use of medication or to repair/replace the mitral valve or aortic valve. [68]

  4. Management of hypertension - Wikipedia

    en.wikipedia.org/wiki/Management_of_hypertension

    Resistant hypertension is defined as hypertension that remains above goal blood pressure in spite of using, at once, three antihypertensive medications belonging to different drug classes. Guidelines for treating resistant hypertension have been published in the UK [45] and US. [46]

  5. Bosentan - Wikipedia

    en.wikipedia.org/wiki/Bosentan

    Bosentan, sold under the brand name Tracleer among others, is a dual endothelin receptor antagonist medication used in the treatment of pulmonary artery hypertension (PAH). [4] [5] Bosentan is available as film-coated tablets (62.5 mg or 125 mg) or as dispersable tablets for oral suspension (32 mg). [4]

  6. Antihypertensive - Wikipedia

    en.wikipedia.org/wiki/Antihypertensive

    Which type of medication to use initially for hypertension has been the subject of several large studies and resulting national guidelines. The fundamental goal of treatment should be the prevention of the important endpoints of hypertension, such as heart attack, stroke and heart failure.

  7. Ambrisentan - Wikipedia

    en.wikipedia.org/wiki/Ambrisentan

    Ambrisentan is a drug that blocks endothelin, an endogenous hormone found in higher quantities in patients with pulmonary arterial hypertension. Endothelin binds to two receptors, ET A and ET B . ET A is responsible for cell growth in the vessels as well as vasoconstriction , while ET B plays a role in vasodilation , endothelin 1 clearance, and ...

  1. Ads

    related to: medication list for pulmonary hypertension patients treatment guidelines